- Home
- NAGE
NAGE
Niagen Bioscience Inc. Common Stock
as 03-28-2025 4:00pm EST
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 594.0M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.31 - $9.18 | Next Earning Date: | 03-04-2025 |
| Revenue: | $99,597,000 | Revenue Growth: | 19.18% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Niagen Bioscience Inc. Common Stock News
NAGE Breaking Stock News: Dive into NAGE Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)
Insider Monkey
4 days ago
Why ChromaDex Corp (CDXC) Is Surging In 2025?
Compare NAGE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NAGE Niagen Bioscience Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.